Hyperbolic Taper Schedule for Escitalopram (Lexapro): A Calm, Evidence-Based Guide

This article is education, not medical advice, and it is not a prescription. Any change to escitalopram should be planned and supervised with your own prescriber, who knows your history. Never stop escitalopram abruptly, even if you feel fine, because the hardest withdrawal effects often arrive days after a cut, not hours.

A few situations need extra caution. If you are also taking a benzodiazepine (such as diazepam, clonazepam, alprazolam, or lorazepam), that is a different and potentially more dangerous taper: abrupt benzodiazepine withdrawal can cause seizures and can be life threatening, and it must be tapered very slowly under medical supervision (the Ashton Manual is the classic reference here). And at any point, if you have thoughts of harming yourself, treat that as an emergency and contact your prescriber, a crisis line, or emergency services right away. Going slowly is a way of being kind to your nervous system, not a sign that something is wrong with you.

The standard advice for years was to halve the dose, then halve it again, then stop, often over just two to four weeks. For some people that works. For many others it sets off weeks or months of dizziness, brain zaps, insomnia, waves of anxiety, crying spells, nausea, and a flu-like heaviness. When that happens, it is easy to conclude that the depression or anxiety has come roaring back and that you are stuck on the medication for good.

But antidepressant withdrawal and relapse are not the same thing, and they often look different in time. Withdrawal symptoms tend to start within days of a dose cut, frequently include physical signs like brain zaps and dizziness that are not typical of your original anxiety or depression, and they tend to ease if the dose is raised back up. A true relapse usually builds more gradually over weeks. If your past attempts fell apart quickly after each drop, that pattern points toward withdrawal driven by tapering too fast, which is fixable, rather than a verdict about your underlying condition.

Here is the core idea, and it is the reason this approach exists. The effect of an SSRI on the brain does not rise in a straight line with the dose. Escitalopram works by blocking the serotonin transporter (SERT), and brain imaging (PET) studies show that the relationship between dose and SERT occupancy is hyperbolic: it climbs very steeply at low doses and then flattens out. Clinically meaningful occupancy, around 80 percent, is already reached at fairly low doses, and going from 10 mg to 20 mg adds only a small amount of additional occupancy.

The practical consequence is the part that changes everything. Near the top of the dose range, dropping a few milligrams barely changes your brain's serotonin signaling. Near the bottom, dropping the same few milligrams can cause a large, abrupt fall in occupancy, and that sudden change is what your nervous system feels as withdrawal. This is exactly why so many people sail through the first cuts from 20 mg and then hit a wall going from 5 mg to nothing. The last few milligrams are doing far more work than their size suggests. Mark Horowitz and David Taylor laid this out in their 2019 Lancet Psychiatry paper, and it is the foundation of the Maudsley Deprescribing Guidelines.

A linear taper cuts by a fixed amount of milligrams each step. On escitalopram that might look like 20, 15, 10, 5, 0. Notice that the final two steps are where occupancy is changing fastest, yet they are the biggest jumps in terms of brain effect. That is the trap.

A hyperbolic taper instead cuts by a fixed percentage of your current dose, so the milligram steps automatically get smaller as the dose gets smaller, keeping the change in brain effect roughly even at each step. A common, conservative rule, used in the Surviving Antidepressants community and consistent with the Maudsley approach, is to reduce by about 10 percent of the most recent dose, then hold, then take 10 percent off the new, lower number. So 10 mg becomes 9, then about 8.1, then 7.3, and so on, with the cuts shrinking to fractions of a milligram as you approach zero. You do not crash to nothing from 5 mg; you glide down through 2 mg, 1 mg, 0.5 mg, and lower.

There is no single correct schedule, and the right one is the one your body tolerates. The Maudsley Deprescribing Guidelines offer faster, moderate, and slower versions of every taper precisely because people differ enormously. Below is an illustrative moderate example starting from 10 mg, reducing by roughly 10 percent of the current dose every two to four weeks. Treat it as a shape, not a rule:

• 10 mg, then about 9, 8, 7.2, 6.5, 5.8
• 5.2, 4.7, 4.2, 3.8, 3.4, 3.1
• 2.8, 2.5, 2.2, 2.0, 1.8, 1.6
• 1.4, 1.3, 1.1, 1.0, 0.8, 0.6, 0.5, 0.4, then stop

Two honest points. First, this is slower than most people expect, often six months to well over a year, and that is normal and intended. Second, the tail matters most: in cohort studies of hyperbolic tapering, the last 10 to 15 percent of the medication often takes longer to come off than the first 85 percent. If a step brings real symptoms, the move is not to push through but to hold at that dose until you stabilize, and to make the next cut smaller. Some people find smaller, more frequent reductions (sometimes called micro-tapering, like the Brassmonkey Slide method described on Surviving Antidepressants) gentler than larger monthly drops.

Hyperbolic tapering sounds simple until you try to take 3.4 mg of a drug that comes as 5, 10, and 20 mg tablets. This is the practical problem that quietly defeats a lot of well-intentioned tapers, so it is worth planning before you start.

You have a few real options, ideally arranged with your prescriber and pharmacist:

• Oral liquid: escitalopram is made as an oral solution (commonly 1 mg/mL in the US, 20 mg/mL in some other countries), which lets you measure small, precise doses with an oral syringe. This is the method the Maudsley guidelines favor for low doses. Because liquid can absorb slightly differently than tablets, many clinicians suggest switching over gradually, for example moving part of your dose from tablet to liquid over a week.
• Tablet splitting: a pill cutter can get you to halves and quarters reliably, but it cannot give you 3.4 mg or 0.6 mg, so it usually only covers the early steps.
• Compounding: a compounding pharmacy can prepare custom low-dose capsules or a suspension for the small end of the taper.
• Dilutions at home: some people make their own liquid by dispersing a tablet in a measured volume of water, but doing this accurately and consistently is genuinely fiddly, and it should be discussed with a pharmacist first.

Note that escitalopram tablets are not designed to be split into beads, so the bead-counting method you may have read about applies to capsule formulations of other antidepressants (like certain venlafaxine or duloxetine products), not to standard Lexapro tablets. Knowing which method fits your specific formulation is half the battle.

The single most useful habit is to let symptoms, not the calendar, drive the schedule. After each reduction, withdrawal effects from escitalopram often show up over the following days because the drug has a half-life of roughly 27 to 33 hours and reaches a new steady state in about a week. So give each step time before judging it, usually at least two to four weeks, and only move down again once you feel back to your stable baseline.

Keeping a simple daily log helps enormously: note your dose, your sleep, and a 0-to-10 rating of how you feel. Over weeks this turns vague suffering into a readable pattern of windows and waves, and it makes the difference between withdrawal and relapse much easier to see with your prescriber. If a cut is clearly too much, it is completely reasonable to step back up to the last dose that felt stable, let things settle, and resume more gently. That is not starting over; that is good tapering.

If you would rather not do this math by hand, Subside can turn these principles into a personalized, day-by-day escitalopram schedule, matched to your formulation, that you can review and adjust with your prescriber. It is one tool among many, and the free communities below are wonderful companions for the lived-experience side of this.

Some of the best, most compassionate knowledge about coming off these medications was built by patients and a handful of pioneering clinicians, often years before mainstream guidelines caught up. These resources are worth your time:

• Surviving Antidepressants: detailed, peer-supported tapering threads, including the 10 percent rule and micro-tapering methods.
• The Maudsley Deprescribing Guidelines (Horowitz and Taylor): the clinical reference for drug-specific hyperbolic schedules.
• Inner Compass Initiative and The Withdrawal Project: plain-language guidance and peer connection for making informed choices.
• BenzoBuddies and the Ashton Manual: the established homes for benzodiazepine tapering, if a benzo is also part of your picture.

Bring what you learn from these communities to your prescriber rather than acting alone. The combination of a slow hyperbolic plan, a supportive prescriber, and a community that gets it is what helps people who have failed before finally get off, and stay off, on their own terms.